KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Net Margin (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Net Margin for 13 consecutive years, with 74.79% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 548.0% to 74.79% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 69.08% through Dec 2025, down 883.0% year-over-year, with the annual reading at 69.08% for FY2025, 883.0% down from the prior year.
  • Net Margin hit 74.79% in Q4 2025 for ClearPoint Neuro, down from 66.48% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 54.27% in Q1 2024 to a low of 119.85% in Q2 2023.
  • Historically, Net Margin has averaged 78.58% across 5 years, with a median of 74.27% in 2022.
  • Biggest five-year swings in Net Margin: tumbled -4651bps in 2021 and later surged 6375bps in 2024.
  • Year by year, Net Margin stood at 96.82% in 2021, then grew by 11bps to 86.37% in 2022, then rose by 20bps to 69.1% in 2023, then decreased by 0bps to 69.31% in 2024, then decreased by -8bps to 74.79% in 2025.
  • Business Quant data shows Net Margin for CLPT at 74.79% in Q4 2025, 66.48% in Q3 2025, and 63.34% in Q2 2025.